Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease

Hepatology Research

Volumn 39, Issue 10, 2009, Pages 972-978

  Schina, Maria ^a   Koskinas, John ^a   Tiniakos, Dina ^b   Hadziyannis, Emilia ^a   Savvas, Savvas ^a   Karamanos, Basil ^a   Manesis, Emanuel ^a   Archimandritis, Athanasios ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Immunohistochemistry; Insulin resistance; Non alcoholic fatty liver disease; Retinol binding protein 4

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; INSULIN; RETINOL BINDING PROTEIN 4;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

EID: 73849146592     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00534.x     Document Type: Article

References (31)

1. Shepherd PR, Kahn BB. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-57.
2. Kahn BB. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-81.
3. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-56.
4. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-62.
5. Graham TE, Yang Q, Bluher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552-63.
6. Marchesini G, Brizi M, Morselli-Labate AM et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-55.
7. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23 (Suppl. 1): S4-19.
8. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatoheaptitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
10. Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 1989; 10: 308-16.
11. Yoshida A, Matsutani Y, Fukuchi Y, Saito K, Naito M. Analysis of the factors contributing to serum retinol binding protein and transthyretin levels in Japanese adults. J Atheroscler Thromb 2006; 13: 209-15.
12. Cho YM, Youn BS, Lee H et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006; 29: 2457-61.
13. Stefan N, Hennige AM, Staiger H et al. High circulating retinol-binding protein 4 is associated with elevated liver fat, but not with total, subcutaneous, visceral, or intramyo-cellular fat in humans. Diabetes Care 2007; 30: 1173-78.
14. Haider DG, Schindler K, Prager G et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007; 92: 1168-71.
15. Gavi S, Stuart LM, Kelly P et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in non-obese subjects without type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 1886-90.
16. Lee DC, Lee JW, Im JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 2007; 56: 327-31.
17. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007; 92: 1971-74.
18. Seo JA, Kim NH, Park SY et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2008; 68: 555-60.
19. Wu H, Jia W, Bao Y et al. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008; 79: 185-90.
20. Petta S, Cammà C, Di Marco V et al. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology 2008; 48: 28-37.
21. Yagmur E, Weiskirchen R, Gressner A, Trautwein C, Tacke F. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 2007; 30: 1168-72.
22. Bahr MJ, Boeker KH, Manns MP, Tietge UJ. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis. Clin Endocrinol (Oxf) 2009; 70: 60-5.
23. Naylor HM, Newcomer ME. The structure of of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochem 1999; 38: 2647-53.
24. Goodman DS. Plasma retinol-binding protein. Ann NY Acad Sci USA 1980; 348: 378-90.
25. Peterson PA, Berggard I. Isolation and properties of a human retinol-transporting protein. J Biol Chem 1971; 246: 25-33.
26. Smith FR, Goodman DS. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest 1971; 50: 2426-36.
27. Ronne H, Ocklind C, Wiman K, Rask L, Obrick B, Peterson PA. Ligand - dependent egulation of intracellular protein transport: effect of vitamin A on the secretion of the retinol-binding protein. J Cell Biol 1983; 96: 907-10.
28. Smith JE, Muto Y, Milch PO, Goodman DS. The effects of chylomicron vitamin A on the metabolism of retinol binding protein in the rat. J Biol Chem 1973; 257: 1544-49.
29. Soprano DR, Smith JE, Goodman DS. Effect of retinol status on retinol-binding protein biosynthesis rate and translatable messenger RNA level in rat liver. J Biol Chem 1982; 257: 7693-97.
30. Soprano DR, Soprano KJ, Goodman DS. Retinol-binding protein messenger RNA levels in the liver and the extrahepatic tissues of the rat. J Lipid Res 1986; 27: 166-71.
31. Frey SK, Nagl B, Henze A et al. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis 2008; 7: 29.